Key result
cMyBP-C deficiency reduces super-relaxed myosin content by ~22 percentage points along the thick filament.
Why the study?
To define how cardiac myosin-binding protein C and its specific domains contribute to stabilizing the myosin super-relaxed state in cardiac muscle.
Absolute Event Rate: 35% vs 57%
p-value: p=<0.001
Cardiac MyBP-C and its N-terminus are crucial for stabilizing the super-relaxed state of myosin along the entire thick filament.
cMyBP-C stabilizes SRX myosin along the thick filament; leaves open therapeutic targeting in human cardiomyopathy.
The myosin super-relaxed (SRX) state is central to striated muscle metabolic and functional regulation. In skeletal muscle, SRX myosin are predominantly colocalized with myosin-binding protein C (MyBP-C) in the sarcomere C-zone. To define how cardiac MyBP-C (cMyBP-C) and its specific domains contribute to stabilizing the SRX state in cardiac muscle, we took advantage of transgenic cMyBP-C null mice and those expressing cMyBP-C with a 271-residue N-terminal truncation. Utilizing super-resolution microscopy, we determined the lifetime and subsarcomeric location of individual fluorescent-ATP turnover events within isolated cardiac myofibrils. The proportion of SRX myosin demonstrated a gradient along the half-thick filament, highest in the P- and C-zones (72 ± 9% and 71 ± 6%, respectively) and lower in the D-zone (45 ± 10%), which lies farther from the sarcomere center and lacks cMyBP-C, suggesting a possible role for cMyBP-C in stabilizing the SRX. However, myofibrils from cMyBP-C null mice demonstrated an ∼40% SRX reduction, not only within the now cMyBP-C-free C-zone (49 ± 9% SRX), but also within the D-zone (22 ± 5% SRX). These data suggest that the influence of cMyBP-C on the SRX state is not limited to the C-zone but extends along the thick filament. Interestingly, myofibrils with N-terminal truncated cMyBP-C had an SRX content and spatial gradient similar to the cMyBP-C null, indicating that the N terminus of cMyBP-C is necessary for cMyBP-C's role in enhancing the SRX gradient along the entire thick filament. Given that SRX myosin exist as a gradient along the thick filament that is highest in the C-zone, even in the absence of cMyBP-C or its N-terminus, an inherent bias must exist in the structure of the thick filament to stabilize the SRX state.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2023) studied Cardiac muscle sarcomere structure and regulation (n=14). cMyBP-C null mutation or N-terminal truncation vs. Wildtype was evaluated on Overall fraction of super-relaxed (SRX) myosin events (p=<0.001). cMyBP-C null myofibrils demonstrated a significant reduction in overall SRX myosin content to 35% compared to 57% in wildtype, extending along the thick filament.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: